Cargando…
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
Immune checkpoint therapy (ICT) using antibody blockade of programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) can provoke T cell–dependent antitumor activity that generates durable clinical responses in some patients. The epigenetic and transcriptional fea...
Autores principales: | Salmon, Avery J., Shavkunov, Alexander S., Miao, Qi, Jarjour, Nicholas N., Keshari, Sunita, Esaulova, Ekaterina, Williams, Charmelle D., Ward, Jeffrey P., Highsmith, Anna M., Pineda, Josué E., Taneja, Reshma, Chen, Ken, Edelson, Brian T., Gubin, Matthew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164498/ https://www.ncbi.nlm.nih.gov/pubmed/35181783 http://dx.doi.org/10.1158/2326-6066.CIR-21-0129 |
Ejemplares similares
-
Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity
por: Jarjour, Nicholas N., et al.
Publicado: (2019) -
IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
por: Lin, Chih-Chung, et al.
Publicado: (2016) -
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation
por: Lin, Chih-Chung, et al.
Publicado: (2014) -
Bhlhe40: Gatekeeper of the GC
por: Nutt, Stephen L., et al.
Publicado: (2021) -
BHLHE40 Mediates Cross-Talk between Pathogenic T(H)17 Cells and Myeloid Cells during Experimental Autoimmune Encephalomyelitis
por: Cook, Melissa E., et al.
Publicado: (2023)